A Bystander Effect of Lung Cancer Chemotherapy on Chronic Echinococcal Disease

por Bangaru, Saroja D., Kozarsky, Phyllis E., Lee, Daniel J., Sica, Gabriel L., Owonikoko, Taofeek K.
Publicado 2015

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

por Xu, Ke, Park, Dongkyoo, Magis, Andrew T., Zhang, Jun, Zhou, Wei, Sica, Gabriel L., Ramalingam, Suresh S., Curran, Walter J., Deng, Xingming
Publicado 2019

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

por Xu, Ke, Park, Dongkyoo, Magis, Andrew T., Zhang, Jun, Zhou, Wei, Sica, Gabriel L., Ramalingam, Suresh S., Curran, Walter J., Deng, Xingming
Publicado 2020

Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

por Li, Rui, You, Shuo, Hu, Zhongliang, Chen, Zhuo G., Sica, Gabriel L., Khuri, Fadlo R., Curran, Walter J., Shin, Dong M., Deng, Xingming
Publicado 2013

Discovery of Small Molecule Bak Activator for Lung Cancer Therapy

por Park, Dongkyoo, Anisuzzaman, Abu Syed Md, Magis, Andrew T., Chen, Guo, Xie, Maohua, Zhang, Guojing, Behera, Madhusmita, Sica, Gabriel L., Ramalingam, Suresh S., Owonikoko, Taofeek K., Deng, Xingming
Publicado 2021

Small Molecule Bax Agonists for Cancer Therapy

por Xin, Meiguo, Li, Rui, Xie, Maohua, Park, Dongkyoo, Owonikoko, Taofeek K., Sica, Gabriel L., Corsino, Patrick E., Zhou, Jia, Ding, Chunyong, White, Mark A., Magis, Andrew T., Ramalingam, Suresh S., Curran, Walter J., Khuri, Fadlo R., Deng, Xingming
Publicado 2014

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

por Owonikoko, Taofeek K., Zhang, Guojing, Kim, Hyun S., Stinson, Renea M., Bechara, Rabih, Zhang, Chao, Chen, Zhengjia, Saba, Nabil F., Pakkala, Suchita, Pillai, Rathi, Deng, Xingming, Sun, Shi-Yong, Rossi, Michael R., Sica, Gabriel L., Ramalingam, Suresh S., Khuri, Fadlo R.
Publicado 2016

Characteristics and anatomic location of PD-1(+)TCF1(+) stem-like CD8 T cells in chronic viral infection and cancer

por Im, Se Jin, Obeng, Rebecca C., Nasti, Tahseen H., McManus, Daniel, Kamphorst, Alice O., Gunisetty, Sivaram, Prokhnevska, Nataliya, Carlisle, Jennifer W., Yu, Ke, Sica, Gabriel L., Cardozo, Lucas E., Gonçalves, André N. A., Kissick, Haydn T., Nakaya, Helder I., Ramalingam, Suresh S., Ahmed, Rafi
Publicado 2023

Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer

por Owonikoko, Taofeek K, Zhang, Guojing, Deng, Xingming, Rossi, Michael R, Switchenko, Jeffrey M, Doho, Gregory H, Chen, Zhengjia, Kim, Sungjin, Strychor, Sandy, Christner, Susan M, Beumer, Jan, Li, Chunyang, Yue, Ping, Chen, Alice, Sica, Gabriel L, Ramalingam, Suresh S, Kowalski, Jeanne, Khuri, Fadlo R, Sun, Shi-Yong
Publicado 2014

Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance

por Boyle, Theresa A., Khalil, Farah K., Mino-Kenudson, Mari, Sica, Gabriel L., Moreira, Andre L., Sholl, Lynette M., Knight, Mirna Z., Zhang, Liping, Saller, James, Varella-Garcia, Marileila, Berry, Lynne D., Chen, Heidi, Ellison, Kim E., Rivard, Christopher J., Kugler, Kelly, Wistuba, Ignacio I., Fujimoto, Junya, Kwiatkowski, David J., Bunn, Paul A., Kris, Mark G., Haura, Eric B., Hirsch, Fred R.
Publicado 2020